Triple trial boost for Lilly's migraine drug
admin 15th May 2017 Uncategorised 0CGRP treatment galcanezumab looks to be course for regulatory submissions
More: Triple trial boost for Lilly's migraine drug
Source: News
CGRP treatment galcanezumab looks to be course for regulatory submissions
More: Triple trial boost for Lilly's migraine drug
Source: News
© 1994 - 2025 B.M. Pharmaceuticals